{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:56:33Z","timestamp":1782330993089,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.encep.2007.12.004","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T09:50:12Z","timestamp":1205401812000},"page":"187-193","source":"Crossref","is-referenced-by-count":6,"title":["Potentialit\u00e9s cliniques et perspectives d\u2019utilisation de l\u2019aripiprazole hors de ses champs classiques d\u2019indication"],"prefix":"10.1016","volume":"34","author":[{"given":"M.-A.","family":"Crocq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Azorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-O.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dal\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2007.12.004_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2004.11.007","article-title":"Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors","volume":"86","author":"Adson","year":"2005","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.encep.2007.12.004_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2190\/33JH-KTV4-BE2W-AW05","article-title":"Aripiprazole in the treatment of delirium","volume":"35","author":"Alao","year":"2005","journal-title":"Int J Psychiatry Med"},{"issue":"Suppl 2","key":"10.1016\/j.encep.2007.12.004_bib3","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/cap.2004.14.593","article-title":"The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review","volume":"14","author":"Barzman","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2007.12.004_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4088\/JCP.v68n0423g","article-title":"Aripiprazole-induced hyponatremia: a case report","volume":"68","author":"Behere","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.jcp.0000169419.38899.5b","article-title":"Aripiprazole in schizophrenia with cocaine dependence: a pilot study","volume":"25","author":"Beresford","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.12.004_bib8","unstructured":"Berman RM, Marcus RN, Swanink R, et al. Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder. A multicenter, randomized, double-blind, placebo-controlled study. Poster NR 310; American Psychiatric Association 160th annual meeting, San Diego, CA, May 19\u201324, 2007."},{"key":"10.1016\/j.encep.2007.12.004_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","article-title":"Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.encep.2007.12.004_bib10","first-page":"P5","article-title":"Pharmacokinetics, tolerability and safety of aripiprazole in children and adolescents with conduct disorder","volume":"71","author":"Blumer","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.encep.2007.12.004_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1478951505050352","article-title":"Atypical antipsychotics in the management of delirium: a review of the empirical literature","volume":"3","author":"Boettger","year":"2005","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.encep.2007.12.004_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v66n0613","article-title":"Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole","volume":"66","author":"Brown","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4088\/JCP.v66n0107","article-title":"The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients","volume":"66","author":"Connor","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hup.798","article-title":"A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole","volume":"21","author":"Davies","year":"2006","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"5","key":"10.1016\/j.encep.2007.12.004_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.jcp.0000178415.22309.8f","article-title":"Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study","volume":"25","author":"De Deyn","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.encep.2007.12.004_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2006.04.010","article-title":"Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse","volume":"61","author":"Feltenstein","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2007.12.004_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002826-200401000-00003","article-title":"Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience","volume":"27","author":"Fernandez","year":"2004","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.encep.2007.12.004_bib18","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1016\/S0924-977X(03)92080-3","article-title":"Aripiprazole in pediatric conduct disorder: a pilot study","volume":"13","author":"Findling","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.12.004_bib19","first-page":"497","article-title":"Behavioural and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment","author":"Finkel","year":"1996","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10.1016\/j.encep.2007.12.004_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0404.1991.tb04918.x","article-title":"Psychotic complications of long-term levodopa treatment of Parkinson's disease","volume":"84","author":"Friedman","year":"1991","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.encep.2007.12.004_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/01.wnl.0000229933.91780.67","article-title":"Atypical antipsychotics in the elderly with Parkinson disease and the \u201cblack box\u201d warning","volume":"67","author":"Friedman","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.encep.2007.12.004_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary or comorbid anxiety symptoms or disorders: a review","volume":"67","author":"Gao","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.encep.2007.12.004_bib23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1345\/aph.1G255","article-title":"Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole","volume":"39","author":"Grant","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2007.12.004_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.pnpbp.2004.06.016","article-title":"Aripiprazole as an adjunctive treatment for refractory major depression","volume":"28","author":"Hellerstein","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11\u201312","key":"10.1016\/j.encep.2007.12.004_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/j.1440-1614.2006.01920.x","article-title":"Antipsychotic medication dispensing and associated odds ratios of death in elderly veterans and war widows, 2001","volume":"40","author":"Hollis","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2007.12.004_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/alcalc\/agl037","article-title":"Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking","volume":"41","author":"Ingman","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.encep.2007.12.004_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2007.12.004_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.jcp.0000150229.69124.66","article-title":"Treatment of tics in Tourette syndrome with aripiprazole","volume":"25","author":"Kastrup","year":"2005","journal-title":"J Clin psychopharmacol"},{"key":"10.1016\/j.encep.2007.12.004_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pnpbp.2006.12.009","article-title":"Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia","volume":"31","author":"Kemp","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2007.12.004_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1176\/appi.neuropsych.17.3.421","article-title":"Aripiprazole in psychosis associated with Parkinson's disease","volume":"17","author":"Lopez-Meza","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"10","key":"10.1016\/j.encep.2007.12.004_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.encep.2007.12.004_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1017\/S1092852900002273","article-title":"Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies","volume":"9","author":"Madhusoodanan","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.encep.2007.12.004_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00406-005-0587-5","article-title":"Antipsychotic and antidepressive effects of second generation antipsychotics. Two different pharmacological mechanisms","volume":"255","author":"M\u00f6ller","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2007.12.004_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00213-007-0740-0","article-title":"Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up","volume":"191","author":"Nickel","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.encep.2007.12.004_bib35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1176\/appi.ajp.163.5.833","article-title":"Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study","volume":"163","author":"Nickel","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib36","first-page":"1","article-title":"Aripiprazole augmentation for treatment of patients with inadequate antidepressants response","volume":"0","author":"Pae","year":"2006","journal-title":"Depress Anxiety"},{"issue":"5","key":"10.1016\/j.encep.2007.12.004_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","article-title":"Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow-up","volume":"75","author":"Pollak","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib38","unstructured":"Robb AS, Findling RL, Nyilas M, et al. Efficacy of aripiprazole in the treatment of schizophrenia. Poster NR 742; American Psychiatric Association 160th Annual Meeting, San Diego, CA, May 19\u201324, 2007."},{"key":"10.1016\/j.encep.2007.12.004_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/08830738050200071301","article-title":"Aripiprazole in children and adolescents: clinical experience","volume":"7","author":"Rugino","year":"2005","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.encep.2007.12.004_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002512-200522010-00003","article-title":"Managing bipolar disorder in the elderly: defining the role of the newer agents","volume":"22","author":"Sajatovic","year":"2005","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.encep.2007.12.004_bib41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0269881106060194","article-title":"A case of aripiprazole and extrapyramidal side effects","volume":"20","author":"Salmoiraghi","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2007.12.004_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"15","key":"10.1016\/j.encep.2007.12.004_bib43","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.encep.2007.12.004_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00213-006-0520-2","article-title":"Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats","volume":"191","author":"Schwabe","year":"2007","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.encep.2007.12.004_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.yic.0000185025.40656.30","article-title":"Aripiprazole-induced parkinsonism","volume":"21","author":"Sharma","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2007.12.004_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1503\/cmaj.050478","article-title":"Increased mortality among elderly patients with dementia using atypical antipsychotics","volume":"173","author":"Singh","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.encep.2007.12.004_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2004.14.455","article-title":"Aripiprazole for maladaptive behavior in pervasive developmental disorders","volume":"14","author":"Stigler","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2007.12.004_bib48","first-page":"1","article-title":"Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder","volume":"0","author":"Storch","year":"2007","journal-title":"Depress Anxiety"},{"issue":"5","key":"10.1016\/j.encep.2007.12.004_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1176\/appi.psy.47.5.385","article-title":"Aripiprazole in the treatment of delirium","volume":"47","author":"Straker","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2007.12.004_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/070674370505000415","article-title":"Aripiprazole reducs alcohol use","volume":"50","author":"Warsi","year":"2005","journal-title":"Can J Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2007.12.004_bib51","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/mds.21025","article-title":"Aripiprazole associated with severe exacerbation of Parkinson's disease","volume":"21","author":"Wickremaratchi","year":"2006","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.encep.2007.12.004_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/070674370505000321","article-title":"Improvement in tardive dyskinesia with aripiprazole use","volume":"50","author":"Witschy","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.12.004_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200501000-00002","article-title":"Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients","volume":"20","author":"Worthington","year":"2005","journal-title":"Int Clin Psychopharmacol"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370060800002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370060800002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T23:20:26Z","timestamp":1557357626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370060800002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S001370060800002X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2007.12.004","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}